Monteverde & Associates PC Investigates Multiple M&A Deals
Analysis based on 30 articles · First reported Mar 30, 2026 · Last updated Apr 16, 2026
The market impact is generally neutral to slightly negative for the target companies due to the uncertainty introduced by the investigations. For the acquiring companies, the impact is also neutral as the investigations are standard procedure for M&A deals.
Monteverde & Associates PC, a class action securities firm, is investigating multiple proposed mergers and acquisitions on behalf of shareholders. The firm, led by Juan Monteverde, is examining the terms of these transactions to determine if they are fair to shareholders. The investigations include the sale of Kezar Life Sciences to Aurinia Pharmaceuticals Inc., Centessa Pharmaceuticals plc to Eli Lilly and Company, Talkspace, Inc. to Universal Health Services, Inc., and Warner Bros. Discovery, Inc. to Paramount Skydance. Additionally, the firm is investigating the merger of Cyclerion Therapeutics, Inc. with Korsana Biosciences, Inc., the sale of Affinity Bancshares, Inc. to Fidelity Bancshares, Inc., Forian Inc. to a consortium led by Max Wygod, Soleno Therapeutics, Inc. to Neurocrine Biosciences, Inc., and McCormick & Company, Incorporated's merger with Unilever's Foods business. The firm aims to recover millions of dollars for shareholders if the deals are found to be unfair.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard